Ellagic Acid Prevents Ca 2+ Dysregulation and Improves Functional Abnormalities of Ventricular Myocy...
Ellagic Acid Prevents Ca 2+ Dysregulation and Improves Functional Abnormalities of Ventricular Myocytes via Attenuation of Oxidative Stress in Pathological Cardiac Hypertrophy
About this item
Full title
Author / Creator
Publisher
United States
Journal title
Language
English
Formats
Publication information
Publisher
United States
Subjects
More information
Scope and Contents
Contents
The aim of this study was to investigate whether ellagic acid (EA) treatment can prevent changes in contractile function and Ca
regulation of cardiomyocytes in pathologic cardiac hypertrophy. Groups were assigned as Con group; an ISO group in which the rats received isoproterenol alone (5 mg/kg/day); and an ISO + EA group in which the rats recei...
Alternative Titles
Full title
Ellagic Acid Prevents Ca 2+ Dysregulation and Improves Functional Abnormalities of Ventricular Myocytes via Attenuation of Oxidative Stress in Pathological Cardiac Hypertrophy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmed_primary_33909254
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmed_primary_33909254
Other Identifiers
E-ISSN
1559-0259
DOI
10.1007/s12012-021-09654-1
